The current valuation score of Fortress Biotech Inc is 9.14, ranking 44 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 0.78, which is 2.68% below the recent high of 0.80 and 5662.31% above the recent low of -43.21.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.